Samsung Biologics

207940.KO

668.32 USD

-7.68

-1.14%

Overview

Last close

668.32 usd

Market cap

30.94B usd

52 week high

761.21 usd

52 week low

634.23 usd

Target price

668.32 usd

Valuation

P/E

N/A

Forward P/E

71.9424

Price/Sales

16.172

Price/Book Value

10.0955

Enterprise Value

49.90B usd

EV/Revenue

16.3847

EV/EBITDA

26.8439

Key financials

Revenue TTM

3.05B usd

Gross Profit TTM

1.67B usd

EBITDA TTM

1.81B usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

7.67B usd

Net debt

533.63M usd

About

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates through Contract Development and Manufacturing Organization (CDMO), and Biopharmaceutical Development and Commercialization segments. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and regulatory support services; and quality, biosafety and analytical testing services, as well as manufactures drug substance. In addition, it engages in the development and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.